Dr James Good

  • MSc PhD FRCR
  • Clinical Oncologist
  • Spoken languages English

Overview

Professional memberships

  • Committee member, UK SABR Consortium
  • Appointed member, NCRI clinical and translational radiotherapy group (CT-Rad)
  • Fellow, Royal College of Radiologists
  • Member, Royal College of Physicians
  • Member, Radiosurgery Society
  • Member, European Society of Medical Oncology

Research interests

Dr Good is the local lead clinician on several clinical trials investigating both immunotherapy and novel radiation techniques. He has a particular interest in novel drug/radiotherapy combinations. He is also on the trial management group of the phase 3 CompARE trial, investigating immunotherapy in combination with radiotherapy, and is deputy chief investigator of the WISTERIA trial, which investigates a DNA damage response modulator with radiotherapy. He is involved in shaping the national research strategy for patients with primary liver cancer and has published a wide range of research work.